HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The selective Na+-Ca2+ exchange inhibitor attenuates brain edema after radiofrequency lesion in rats.

Abstract
2-[4-[(2,5-Difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline (SEA0400), a specific inhibitor of the Na+-Ca2+ exchanger, exerts cytoprotective action and reduces brain infarct volume after cerebral ischemia. We examined the effect of SEA0400 on vasogenic brain edema in rats. Histological observations showed that radiofrequency current caused brain infarct and extravasation of endogenous albumin in the brain. SEA0400 (3 and 10 mg/kg, i.v.) significantly suppressed the increase in brain water content with attenuation of Evans blue dye and sodium fluorescein extravasation after radiofrequency lesion. The findings suggest that the Na+-Ca2+ exchanger plays a role in vasogenic edema formation after radiofrequency lesion.
AuthorsYutaka Koyama, Shigeo Matsui, Soichi Itoh, Masakazu Osakada, Akemichi Baba, Toshio Matsuda
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 489 Issue 3 Pg. 193-6 (Apr 12 2004) ISSN: 0014-2999 [Print] Netherlands
PMID15087242 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aniline Compounds
  • Phenyl Ethers
  • SEA 0400
  • Serum Albumin
  • Sodium-Calcium Exchanger
  • Evans Blue
  • Fluorescein
Topics
  • Aniline Compounds (administration & dosage, pharmacokinetics, therapeutic use)
  • Animals
  • Brain Chemistry
  • Brain Edema (etiology, pathology, prevention & control)
  • Brain Infarction (etiology, pathology)
  • Catheter Ablation (adverse effects)
  • Evans Blue (metabolism)
  • Extravasation of Diagnostic and Therapeutic Materials (metabolism, prevention & control)
  • Fluorescein (metabolism)
  • Injections, Intravenous
  • Male
  • Phenyl Ethers (administration & dosage, pharmacokinetics, therapeutic use)
  • Rats
  • Rats, Wistar
  • Serum Albumin (drug effects, metabolism)
  • Sodium-Calcium Exchanger (antagonists & inhibitors, metabolism, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: